Skip to main content
SpringerLink
Log in

Inhibition of osteoblastic differentiation by warfarin and 18-α-glycyrrhetinic acid

  • Research Articles
  • Drug Actions
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

Anticoagulation therapy with vitamin K antagonists such as warfarin is widely used to prevent and treat stroke in patients with chronic atrial fibrillation or mechanical heart valves. Because vitamin K is an essential factor for ggg-carboxylation of osteocalcin, vitamin K antagonists might cause bone loss. Although the association between warfarin use and bone metabolism is still controversial, several studies show that bone mineral density is decreased and fracture risk is increased with warfarin therapy. Meanwhile, attenuation of gap junctional communication (GJC) by warfarin is reported in rat liver epithelial cells. However, the effect of warfarin on osteoblasts, in which GJC is important for osteoblastic differentiation, remains unknown. Here we investigated whether warfarin has an inhibitory effect on osteoblastic differentiation using an osteoblastic cell line (C2C12). Warfarin and 18-α-glycyrrhetinic acid (AGA), which is known as a nontoxic reversible GJC inhibitor, had the same effect on osteoblastic differentiation. Warfarin and AGA inhibited the bone morphogenetic protein (BMP)2-induced mRNA levels of alkaline phosphatase (ALP), collagen I α1, osteocalcin (OC) and osterix, which are specific markers for osteoblastic differentiation, in a dose-dependent manner. Moreover, the activities of OC- and ALP-luciferase reporters, which are induced by BMP2, and the transcriptional activity of Runx2 on OC and ALP promoters were inhibited by warfarin and AGA. The amount and activity of ALP induced by BMP2 were also decreased by warfarin and AGA. These results suggest that warfarin and AGA, a GJC inhibitor, have an inhibitory effect on osteoblastic differentiation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abdelmohsen, K., Stuhlmann, D., Daubrawa, F., and Klotz, L. O., Dicumarol is a potent reversible inhibitor of gap junctional intercellular communication. Arch. Biochem. Biophys., 434, 241–247 (2005).

    Article  PubMed  CAS  Google Scholar 

  • Banerjee, C., Mccabe, L. R., Choi, J. Y., Hiebert, S. W., Stein, J. L., Stein, G. S., and Lian, J. B., Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. J. Cell. Biochem., 66, 1–8 (1997).

    Article  PubMed  CAS  Google Scholar 

  • Bitensky, L., Hart, J. P., Catterall, A., Hodges, S. J., Pilkington, M. J., and Chayen, J., Circulating vitamin K levels in patients with fractures. J. Bone Joint Surg. Br., 70, 663–664 (1988).

    PubMed  CAS  Google Scholar 

  • Caraballo, P. J., Gabriel, S. E., Castro, M. R., Atkinson, E. J., and Melton, L. J., 3rd, Changes in bone density after exposure to oral anticoagulants: a meta-analysis. Osteoporos. Int., 9, 441–448 (1999a).

    Article  PubMed  CAS  Google Scholar 

  • Caraballo, P. J., Heit, J. A., Atkinson, E. J., Silverstein, M. D., O’Fallon, W. M., Castro, M. R., and Melton, L. J., 3rd, Long-term use of oral anticoagulants and the risk of fracture. Arch. Intern. Med., 159, 1750–1756 (1999b).

    Article  PubMed  CAS  Google Scholar 

  • Chung, D. J., Castro, C. H., Watkins, M., Stains, J. P., Chung, M. Y., Szejnfeld, V. L., Willecke, K., Theis, M., and Civitelli, R., Low peak bone mass and attenuated anabolic response to parathyroid hormone in mice with an osteoblast-specific deletion of connexin43. J. Cell Sci., 119, 4187–4198 (2006).

    Article  PubMed  CAS  Google Scholar 

  • Civitelli, R., Beyer, E. C., Warlow, P. M., Robertson, A. J., Geist, S. T., and Steinberg, T. H., Connexin43 mediates direct intercellular communication in human osteoblastic cell networks. J. Clin. Invest., 91, 1888–1896 (1993).

    Article  PubMed  CAS  Google Scholar 

  • Donahue, H. J., McLeod, K. J., Rubin, C. T., Andersen, J., Grine, E. A., Hertzberg, E. L., and Brink, P. R., Cell-to-cell communication in osteoblastic networks: cell line-dependent hormonal regulation of gap junction function. J. Bone Miner. Res., 10, 881–889 (1995).

    Article  PubMed  CAS  Google Scholar 

  • Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L., and Karsenty, G., Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell, 89, 747–754 (1997).

    Article  PubMed  CAS  Google Scholar 

  • Gage, B. F., Birman-Deych, E., Radford, M. J., Nilasena, D. S., and Binder, E. F., Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2. Arch. Intern. Med., 166, 241–246 (2006).

    Article  PubMed  CAS  Google Scholar 

  • Hauschka, P. V., Lian, J. B., and Gallop, P. M., Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue. Proc. Natl. Acad. Sci. U. S. A., 72, 3925–3929 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Hauschka, P. V. and Reid, M. L., Vitamin D dependence of a calcium-binding protein containing gamma-carboxyglutamic acid in chicken bone. J. Biol. Chem., 253, 9063–9068 (1978).

    PubMed  CAS  Google Scholar 

  • Hodges, S. J., Akesson, K., Vergnaud, P., Obrant, K., and Delmas, P. D., Circulating levels of vitamins K1 and K2 decreased in elderly women with hip fracture. J. Bone Miner. Res., 8, 1241–1245 (1993).

    Article  PubMed  CAS  Google Scholar 

  • Jamal, S. A., Browner, W. S., Bauer, D. C., and Cummings, S. R., Warfarin use and risk for osteoporosis in elderly women. Study of Osteoporotic Fractures Research Group. Ann. Intern. Med., 128, 829–832 (1998).

    PubMed  CAS  Google Scholar 

  • Kamijo, M., Haraguchi, T., Tonogi, M., and Yamane, G. Y., The function of connexin 43 on the differentiation of rat bone marrow cells in culture. Biomed. Res., 27, 289–295 (2006).

    Article  PubMed  CAS  Google Scholar 

  • Klotz, L. O., Patak, P., Ale-Agha, N., Buchczyk, D. P., Abdelmohsen, K., Gerber, P. A., von Montfort, C., and Sies, H., 2-Methyl-1,4-naphthoquinone, vitamin K(3), decreases gap-junctional intercellular communication via activation of the epidermal growth factor receptor/extra-cellular signal-regulated kinase cascade. Cancer Res., 62, 4922–4928 (2002).

    PubMed  CAS  Google Scholar 

  • Koshihara, Y. and Hoshi, K., Vitamin K2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro. J. Bone Miner. Res., 12, 431–438 (1997).

    Article  PubMed  CAS  Google Scholar 

  • Lampe, P. D., TenBroek, E. M., Burt, J. M., Kurata, W. E., Johnson, R. G., and Lau, A. F., Phosphorylation of connexin43 on serine368 by protein kinase C regulates gap junctional communication. J. Cell Biol., 149, 1503–1512 (2000).

    Article  PubMed  CAS  Google Scholar 

  • Lecanda, F., Towler, D. A., Ziambaras, K., Cheng, S. L., Koval, M., Steinberg, T. H., and Civitelli, R., Gap junctional communication modulates gene expression in osteoblastic cells. Mol. Biol. Cell, 9, 2249–2258 (1998).

    PubMed  CAS  Google Scholar 

  • Loo, L. W., Berestecky, J. M., Kanemitsu, M. Y., and Lau, A. F., pp60src-mediated phosphorylation of connexin 43, a gap junction protein. J. Biol. Chem., 270, 12751–12761 (1995).

    Article  PubMed  CAS  Google Scholar 

  • Majerus, P. W. and Tollefsen, D. M., The Pharmacological Basis of Therapeutics, McGraw-Hill, New York, (2001).

    Google Scholar 

  • Mamdani, M., Upshur, R. E., Anderson, G., Bartle, B. R., and Laupacis, A., Warfarin therapy and risk of hip fracture among elderly patients. Pharmacotherapy, 23, 1–4 (2003).

    Article  PubMed  Google Scholar 

  • Menon, R. K., Gill, D. S., Thomas, M., Kernoff, P. B., and Dandona, P., Impaired carboxylation of osteocalcin in warfarin-treated patients. J. Clin. Endocrinol. Metab., 64, 59–61 (1987).

    Article  PubMed  CAS  Google Scholar 

  • Pilon, D., Castilloux, A. M., Dorais, M., and LeLorier, J., Oral anticoagulants and the risk of osteoporotic fractures among elderly. Pharmacoepidemiol. Drug Saf., 13, 289–294 (2004).

    Article  PubMed  CAS  Google Scholar 

  • Price, P. A., Otsuka, A. A., Poser, J. W., Kristaponis, J., and Raman, N., Characterization of a gamma-carboxyglutamic acid-containing protein from bone. Proc. Natl. Acad. Sci. U. S. A., 73, 1447–1451 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Rezaieyazdi, Z., Falsoleiman, H., Khajehdaluee, M., Saghafi, M., and Mokhtari-Amirmajdi, E., Reduced bone density in patients on long-term warfarin. Int. J. Rheum. Dis., 12, 130–135 (2009).

    Article  PubMed  Google Scholar 

  • Sadler, J. E., Medicine: K is for koagulation. Nature, 427, 493–494 (2004).

    Article  PubMed  CAS  Google Scholar 

  • Sato, Y., Honda, Y., Kunoh, H., and Oizumi, K., Long-term oral anticoagulation reduces bone mass in patients with previous hemispheric infarction and nonrheumatic atrial fibrillation. Stroke, 28, 2390–2394 (1997).

    Article  PubMed  CAS  Google Scholar 

  • Schiller, P. C., Roos, B. A., and Howard, G. A., Parathyroid hormone up-regulation of connexin 43 gene expression in osteoblasts depends on cell phenotype. J. Bone Miner. Res., 12, 2005–2013 (1997).

    Article  PubMed  CAS  Google Scholar 

  • Schiller, P. C., D’Ippolito, G., Balkan, W., Roos, B. A., and Howard, G. A., Gap-junctional communication is required for the maturation process of osteoblastic cells in culture. Bone, 28, 362–369 (2001a).

    Article  PubMed  CAS  Google Scholar 

  • Schiller, P. C., D’Ippolito, G., Balkan, W., Roos, B. A., and Howard, G. A., Gap-junctional communication mediates parathyroid hormone stimulation of mineralization in osteoblastic cultures. Bone, 28, 38–44 (2001b).

    Article  PubMed  CAS  Google Scholar 

  • Schiller, P. C., D’Ippolito, G., Brambilla, R., Roos, B. A., and Howard, G. A., Inhibition of gap-junctional communication induces the trans-differentiation of osteoblasts to an adipocytic phenotype in vitro. J. Biol. Chem., 276, 14133–14138 (2001c).

    PubMed  CAS  Google Scholar 

  • Simon, R. R., Beaudin, S. M., Johnston, M., Walton, K. J., and Shaughnessy, S. G., Long-term treatment with sodium warfarin results in decreased femoral bone strength and cancellous bone volume in rats. Thromb. Res., 105, 353–358 (2002).

    Article  PubMed  CAS  Google Scholar 

  • Sugiyama, T., Takaki, T., Sakanaka, K., Sadamaru, H., Mori, K., Kato, Y., Taguchi, T., and Saito, T., Warfarin-induced impairment of cortical bone material quality and compensatory adaptation of cortical bone structure to mechanical stimuli. J. Endocrinol., 194, 213–222 (2007).

    Article  PubMed  CAS  Google Scholar 

  • Szulc, P., Chapuy, M. C., Meunier, P. J., and Delmas, P. D., Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J. Clin. Invest., 91, 1769–1774 (1993).

    Article  PubMed  CAS  Google Scholar 

  • Szulc, P., Arlot, M., Chapuy, M. C., Duboeuf, F., Meunier, P. J., and Delmas, P. D., Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J. Bone Miner. Res., 9, 1591–1595 (1994).

    Article  PubMed  CAS  Google Scholar 

  • Szulc, P., Chapuy, M. C., Meunier, P. J., and Delmas, P. D., Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study. Bone, 18, 487–488 (1996).

    Article  PubMed  CAS  Google Scholar 

  • Upham, B. L., Suzuki, J., Chen, G., Wang, Y., McCabe, L. R., Chang, C. C., Krutovskikh, V. A., Yamasaki, H., and Trosko, J. E., Reduced gap junctional intercellular communication and altered biological effects in mouse osteoblast and rat liver oval cell lines transfected with dominantnegative connexin 43. Mol. Carcinog., 37, 192–201 (2003).

    Article  PubMed  CAS  Google Scholar 

  • Warn-Cramer, B. J., Lampe, P. D., Kurata, W. E., Kanemitsu, M. Y., Loo, L. W., Eckhart, W., and Lau, A. F., Characterization of the mitogen-activated protein kinase phosphorylation sites on the connexin-43 gap junction protein. J. Biol. Chem., 271, 3779–3786 (1996).

    Article  PubMed  CAS  Google Scholar 

  • Woo, C., Chang, L. L., Ewing, S. K., and Bauer, D. C., Single-point assessment of warfarin use and risk of osteoporosis in elderly men. J. Am. Geriatr. Soc., 56, 1171–1176 (2008).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Pharmacy and Research Institute of Drug Development, Chonnam National University, Gwangju, 500-757, Korea

    Hyung Min Jeong, Yun Hye Jin & Kwang Youl Lee

  2. Division of Endocrinology and Metabolism, Department of Internal Medicine, Chonnam National University Medical School, Gwangju, 501-746, Korea

    Dong Hyeok Cho, Jin Ook Chung, Min Young Chung & Dong Jin Chung

Authors
  1. Hyung Min Jeong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dong Hyeok Cho
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yun Hye Jin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jin Ook Chung
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Min Young Chung
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Dong Jin Chung
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kwang Youl Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kwang Youl Lee.

Additional information

These authors contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jeong, H.M., Cho, D.H., Jin, Y.H. et al. Inhibition of osteoblastic differentiation by warfarin and 18-α-glycyrrhetinic acid. Arch. Pharm. Res. 34, 1381–1387 (2011). https://doi.org/10.1007/s12272-011-0819-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12272-011-0819-3

Key words

Search

Navigation